Cargando…

Limited Effect of Indolamine 2,3-Dioxygenase Expression and Enzymatic Activity on Lupus-Like Disease in B6.Nba2 Mice

B6.Nba2 mice spontaneously develop a lupus-like disease characterized by elevated levels of serum anti-nuclear autoantibody (ANA) immune complexes and constitutive type I interferon (IFNα) production. During disease progression, both plasmacytoid dendritic cells (pDCs) and antibody secreting plasma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davison, Laura M., Liu, Jessica C., Huang, Lei, Carroll, Thomas M., Mellor, Andrew L., Jørgensen, Trine N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727869/ https://www.ncbi.nlm.nih.gov/pubmed/31555267 http://dx.doi.org/10.3389/fimmu.2019.02017

Ejemplares similares

Macrophages/Microglia Represent the Major Source of Indolamine 2,3-Dioxygenase Expression in Melanoma Metastases of the Brain
por: Herrera-Rios, Dayana, et al.
Publicado: (2020)

Combined radiotherapy and immunotherapy using CPG oligodeoxynucleotides and indolamine 2,3 dioxygenase (IDO) blockade
por: Monjazeb, Arta M, et al.
Publicado: (2013)

Butyrate Produced by Commensal Bacteria Down-Regulates Indolamine 2,3-Dioxygenase 1 (IDO-1) Expression via a Dual Mechanism in Human Intestinal Epithelial Cells
por: Martin-Gallausiaux, Camille, et al.
Publicado: (2018)

Need to focus on inhibitory activity of benzimidazole analogues against indolamine 2,3-dioxygenase-1 (IDO-1)
por: Sharma, Akshansh, et al.
Publicado: (2022)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
por: Mellor, Andrew L., et al.
Publicado: (2017)

Blocking indolamine 2,3 dioxygenase mediated rebound immune suppression improves systemic anti-tumor effects of radio-immunotherapy
por: Monjazeb, Arta M, et al.
Publicado: (2015)

Spontaneous CD4+ T Cell Activation and Differentiation in Lupus-Prone B6.Nba2 Mice Is IFNAR-Independent
por: Keller, Emma J., et al.
Publicado: (2022)

Editorial: Targeting Indoleamine 2,3-dioxygenases and Tryptophan Dioxygenase for Cancer Immunotherapy
por: Brochez, Lieve, et al.
Publicado: (2021)

Combined Inhibition of Indolamine-2,3-Dioxygenase 1 and C-X-C Chemokine Receptor Type 2 Exerts Antitumor Effects in a Preclinical Model of Cervical Cancer
por: Lizcano-Meneses, Solangy, et al.
Publicado: (2023)

Curcumin combined with FAPαc vaccine elicits effective antitumor response by targeting indolamine-2,3-dioxygenase and inhibiting EMT induced by TNF-α in melanoma
por: Jiang, Guan-Min, et al.
Publicado: (2015)

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
por: Hornyák, Lilla, et al.
Publicado: (2018)

Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis
por: Wirthgen, Elisa, et al.
Publicado: (2015)

Targeting Indoleamine 2,3-Dioxygenase 1: Fighting Cancers via Dormancy Regulation
por: Yang, Chao, et al.
Publicado: (2021)

Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
por: Song, Xiaotian, et al.
Publicado: (2021)

The role of indoleamine 2,3-dioxygenase 1 in early-onset post-stroke depression
por: Chen, Hengshu, et al.
Publicado: (2023)

Probiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study
por: Scagnolari, Carolina, et al.
Publicado: (2016)

Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus
por: Jones, Jessica M., et al.
Publicado: (2020)

High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer
por: Wei, Lijuan, et al.
Publicado: (2018)

What May Constrain the Success of Indoleamine 2,3-Dioxygenase 1 Inhibitors in Cancer Immunotherapy?
por: Eleftheriadis, Theodoros
Publicado: (2018)

Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review
por: Wells, Georgia, et al.
Publicado: (2021)

Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma
por: Mohapatra, Soumya R., et al.
Publicado: (2019)

Associations of microbial and indoleamine-2,3-dioxygenase-derived tryptophan metabolites with immune activation in healthy adults
por: Riazati, Niknaz, et al.
Publicado: (2022)

Interleukin-6 and indoleamine-2,3-dioxygenase as potential adjuvant targets for Papillomavirus-related tumors immunotherapy
por: Pagni, Roberta Liberato, et al.
Publicado: (2022)

Indoleamine 2,3-dioxygenase 1 signaling orchestrates immune tolerance in Echinococcus multilocularis-infected mice
por: Meng, Ru, et al.
Publicado: (2022)

Melatonin: A Novel Indolamine in Oral Health and Disease
por: Chava, V. K., et al.
Publicado: (2012)

Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0
por: Grobben, Yvonne, et al.
Publicado: (2021)

Identification of an evolutionary conserved structural loop that is required for the enzymatic and biological function of tryptophan 2,3-dioxygenase
por: Michels, Helen, et al.
Publicado: (2016)

Disease Tolerance Mediated by Phosphorylated Indoleamine-2,3 Dioxygenase Confers Resistance to a Primary Fungal Pathogen
por: de Araújo, Eliseu Frank, et al.
Publicado: (2017)

A Multifaceted Role of Tryptophan Metabolism and Indoleamine 2,3-Dioxygenase Activity in Aspergillus fumigatus–Host Interactions
por: Choera, Tsokyi, et al.
Publicado: (2018)

Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice
por: Forteza, Maria J., et al.
Publicado: (2018)

Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance
por: Hoffmann, Delia, et al.
Publicado: (2020)

Indoleamine 2,3-Dioxygenase Cannot Inhibit Chlamydia trachomatis Growth in HL-60 Human Neutrophil Granulocytes
por: Virok, Dezső P., et al.
Publicado: (2021)

GBP1 Facilitates Indoleamine 2,3-Dioxygenase Extracellular Secretion to Promote the Malignant Progression of Lung Cancer
por: Meng, Yinnan, et al.
Publicado: (2021)

Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
por: Heeren, A. Marijne, et al.
Publicado: (2018)

Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression
por: Banzola, Irina, et al.
Publicado: (2018)

The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes
por: Mondanelli, Giada, et al.
Publicado: (2017)

Localization of Indoleamine 2,3-Dioxygenase-1 and Indoleamine 2,3-Dioxygenase-2 at the Human Maternal-Fetal Interface
por: Kudo, Yoshiki, et al.
Publicado: (2020)

A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases
por: Zhou, Qihui, et al.
Publicado: (2021)

Virus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 Dioxygenase
por: Huang, Lei, et al.
Publicado: (2016)

Commentary: Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells
por: Maffia, Pasquale, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bei47mmdp0edlbvhnbnejr74cm